WRA Science and Technology Fund
- $13.50 NAV as of 9/23/2016
- ($-0.10) / -0.74% Daily NAV Change
- -0.22% YTD (NAV)
Focused on growth. Rooted in innovation
- Excellent track record
- Strong historical results, managed by Zachary Shafran, with more than 20 years of experience.
- Multiple, non-correlated sources of growth
- Seeks opportunities within technology, health care, and applied science and technology.
- Proven investment process
- Built on a six-decade firm legacy of technology investing expertise
Morningstar Style Box
Zachary H. Shafran
- Waddell & Reed Investment Management Company
- 15 Years with Fund
- 28 Years in Industry
Zachary H. Shafran is a senior vice president of Waddell & Reed Investment Management Company. Mr. Shafran graduated from the University of Missouri at Kansas City in 1988 with a BSBA degree in Business Administration. He earned an MBA with an emphasis in Finance from the University of Missouri at Kansas City in 1992. Prior to joining Waddell & Reed, Mr. Shafran was affiliated with Piper, Jaffray & Hopwood as an investment executive from 1988 through 1990. Mr. Shafran joined Waddell & Reed in June 1990 as an investment analyst. He was promoted to assistant vice president in 1993, vice president in 1996. He was named portfolio manager of the Waddell & Reed Advisors Science and Technology Fund in February 2001. Mr. Shafran is a member of the Kansas City Society of Financial Analysts.
Growth of a $10,000 Investment
Assumes an investment over 10 years or life of the share class, reinvestment of dividends and capital gains, and does not include the effect of sales charges or taxes.
Portfolio Manager Zachary Shafran discusses how innovative technology creates investment opportunities and challenges.
Daily Prices as of 9/23/2016
|Net Asset Value (NAV)||$13.50|
|Daily NAV Change ($)||($-0.10)||-0.74%|
|Weekly NAV Change ($)||$0.19||1.43%|
|Public Offering Price (POP)||$14.32|
|Fund Type||Specialty Funds|
|Fiscal Year End||June|
|Dividends Paid||June, December|
|Fund Assets (as of 8/31/2016)||$3.2 bil|
|Total Equity Holdings (as of 8/31/2016)||54|
|Total Holdings (as of 8/31/2016)||80|
|Portfolio Turnover Rate (as of 6/30/2016)||9%|
|Lipper Category||Science & Technology Funds|
|Benchmark||S&P North American Technology TR|
Data quoted is past performance and current performance may be lower or higher. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost.
Performance at NAV does not include the effect of sales charges. Class A shares, including sales charges, reflects the maximum applicable front-end sales load.
Monthly Rates of Return
|Fund with 5.75% sales charge||-7.80%||-6.76%||4.37%||11.87%||9.25%||11.37%|
|Fund at NAV||-2.14%||-1.08%||6.44%||13.21%||9.89%||11.48%|
|Lipper Science & Technology Funds||7.98%||14.83%||14.31%||14.20%||9.20%||—|
|S&P North American Technology TR||10.01%||20.17%||17.87%||17.31%||11.26%||—|
Quarterly Rates of Return
|Fund with 5.75% sales charge||-14.90%||-20.92%||3.10%||8.47%||8.56%||11.27%|
|Fund at NAV||-9.68%||-16.09%||5.16%||9.75%||9.21%||11.37%|
|Lipper Science & Technology Funds||-1.85%||-1.19%||12.74%||9.51%||8.28%||—|
|S&P North American Technology TR||0.23%||7.69%||15.61%||13.64%||10.58%||—|
Calendar Year Return
|S&P North American Technology TR||-0.88||15.23||34.57||15.28||9.91|
Morningstar Ratings as of 8/31/2016
|Ratings are based on risk-adjusted returns|
|Overall out of 194|
|3 Year out of 194|
|5 Year out of 188|
|10 Year out of 151|
Lipper Ranking through 8/31/2016
|Rankings are based on average annual total returns, but do not consider sales charges.|
Expense Ratios as of 10/30/2015
5-Year Standard Deviation as of 8/31/2016
|S&P North American Technology TR||14.70|
5-Year MPT* Statistics as of 8/31/2016
|*Modern Portfolio Theory|
Historical Prices Inception 5/16/1950
|Date||Price||Dividend Reinvest Date||Capital Gain Reinvest Date|
Historical Distributions Inception 5/16/1950
|Ex-date||Income||Capital Gains||Reinvest Gains||Payment Date|
|12/10/2015||$0||Long: $1.067 Short: $0.000||$13.66||12/10/2015|
|12/11/2014||$0||Long: $1.456 Short: $0.000||$14.9||12/11/2014|
|12/12/2013||$0||Long: $1.363 Short: $0.000||$15.2||12/12/2013|
|12/13/2012||$0||Long: $0.233 Short: $0.000||$10.97||12/13/2012|
|12/8/2011||$0||Long: $0.680 Short: $0.153||$8.83||12/8/2011|
The table includes the daily prices at NAV (net asset value) for the history of this fund's selected share class. NAV is the amount per share you would receive if you sold shares that day.
Top 10 Equity Holdings as a % of net assets 8/31/2016
|Micron Technology, Inc.||Micron Technology, Inc., engages in the manufacture and marketing of semiconductor devices worldwide.||5.11%|
|Aspen Technology, Inc.||Aspen Technology, Inc., together with its subsidiaries, develops and supplies integrated software and services that enable the process industries to design, operate, manage, and optimize their business processes.||5.02%|
|Alliance Data Systems Corp.||Alliance Data Systems Corporation,provides data-driven and transaction-based marketing and customer loyalty solutions primarily in the United States and Canada.||4.45%|
|Microsoft Corp.||Microsoft Corporation is a multinational computer technology corporation that develops, manufactures, licenses and supports a wide range of software products for computing devices.||4.05%|
|Euronet Worldwide, Inc.||Euronet Worldwide, Inc. is an electronic payments provider of payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, individual consumers.||4.04%|
|Microsemi Corp.||Manufacturer of power-related applications including circuits and microchips for defense, aerospace, security and medical industries||3.97%|
|Vertex Pharmaceuticals, Inc.||Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide.||3.95%|
|Cerner Corp.||Cerner Corporation (Cerner) is a supplier of healthcare information technology (HIT) solutions, healthcare devices and related services. Cerner solutions optimize processes for healthcare organizations.||3.78%|
|WNS (Holdings) Ltd. ADR||WNS (Holdings) Limited provides business process management services comprising data, voice, analytical, and business transformation services worldwide||3.58%|
|ACI Worldwide, Inc.||ACI Worldwide, Inc. engages in the development, marketing, installation, and support of software products and services to facilitate electronic payments worldwide.||3.22%|
Total Portfolio Holdings
as a % of equity assets as of 8/31/2016
|Median Market Cap (as of 8/31/2016)||$3.2 bil|
Top 10 Industry Allocation
as a % of Equity Holdings as of 8/31/2016
|Data Processing & Outsourced Services||13.6%|
|Internet Software & Services||10.5%|
|IT Consulting & Other Services||4.4%|
|Health Care Technology||4.0%|
as a % of equity assets as of 8/31/2016
as a % of net assets as of 8/31/2016
|Domestic Common Stock||78.75%|
|Foreign Common Stock||15.90%|
|Cash and Cash Equivalents||4.90%|
|Other Financial Instruments||0.01%|
Equity Country Allocation
as a % of equity assets as of 8/31/2016
Total Portfolio HoldingsUpdated quarterly, upon availability.
Risk Factors: The value of the Fund’s shares will change, and you could lose money on your investment. Because the Fund invests more than 25% of its total assets in the science and technology industry, the Fund’s performance may be more susceptible to a single economic, regulatory or technological occurrence than a fund that does not concentrate its investments in this industry. Securities of companies within specific industries or sectors of the economy may periodically perform differently than the overall market. In addition, the Fund’s performance may be more volatile than an investment in a portfolio of broad market securities and may underperform the market as a whole, due to the relatively limited number of issuers of science and technology related securities. Investment risks associated with investing in science and technology securities, in addition to other risks, include: operating in rapidly changing fields, abrupt or erratic market movements, limited product lines, markets or financial resources, management that is dependent on a limited number of people, short product cycles, aggressive pricing of products and services, new market entrants and obsolescence of existing technology. These and other risks are more fully described in the Fund’s prospectus.
Stylebox: The Morningstar Equity style box reveals a fund's investment strategy by displaying the fund's investment style and the market capitalization of the stocks owned.
The S&P North American Technology Sector Index is an unmanaged index comprised of U.S. securities classified under the GICS® technology sector and internet retail sub-industry. It is not possible to invest directly in an index.”
Performance results for some funds may include the effect of expense reduction arrangements. If those arrangements had not been in place, the performance results would have been lower.
Fee Waiver and/or Expense Reimbursement: Through July 31, 2017, Ivy Investment Management Company (IICO), the Fund's investment manager, Ivy Distributors, Inc. (IDI), the Fund's Distributor, and/or Waddell & Reed Services Company, doing business as WI Services Company (WISC), the Fund's transfer agent, have contractually agreed to reimburse sufficient management fees, 12b-1 fees and/or shareholder servicing fees to cap the total annual ordinary fund operating expenses for the Fund's Class A shares at 1.51%, Class I shares at 1.16%, and Class Y shares at 1.51. Prior to that date, the expense limitation may not be terminated by IICO, IDI, WISC or the Board of Trustees.
Pricing: All prices and year-to-date returns are based on closing quotes unless noted, as supplied to the NASDAQ by 6:00 p.m. Eastern time.
Unsubsidized yields reflect what the yield would have been without the effect of reimbursements and waivers. The adviser and its affiliates have or may voluntarily waive a portion of their fees (including, but not limited to, distribution and service (12b-1) fees) and reimburse certain expenses. There is no guarantee that the fund will avoid a negative yield. Such undertaking may be amended or withdrawn at any time.
12-Month Trailing Distribution Yield: at NAV refers to the 12-month historical cash flow paid over the past 12 months in dividends, divided by the past months ending NAV.
Alpha, Beta, R-Squared, Standard Deviation, Sharpe Ratio and Capture Ratio are 5 year statistics. Alpha is a measure of a fund's actual returns and expected performance, given its level of risk (as measured by beta). Beta reflects the sensitivity of the fund's return to fluctuations in the market index. R-squared indicates how much of a fund's fluctuations were attributable to movements in the fund's benchmark. Standard deviation is a measure of how volatile a fund's returns are. Sharpe ratio is a measure of a fund's risk-adjusted performance. Capture ratio reflects the annualized product of fund vs. index returns for all months in which the index had a positive return (upside capture) or negative return (downside capture).
Morningstar Ratings: For each fund with at least a 3-year history, Morningstar calculates a risk-adjusted return measure that accounts for variation in a fund's monthly performance (including the effects of all sales charges), placing emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund and rated separately.) A fund's overall rating is derived from a weighted average of the 3-, 5- and 10-year (if applicable) rating metrics. Morningstar Rating is for the share classes specified; other classes may have different performance characteristics.
Information is subject to change and is not intended to represent any past or future investment recommendations.
Please remember that an investment in a mutual fund involves risk. Investment return and principal value of a mutual fund investment will fluctuate, and shares, when redeemed, may be worth more or less than their original cost.
YTD Prices can be updated 3 to 4 hours after the Daily Pricing information which can result in mismatching data.